Mark Bond
Impact in
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms
- NF-κB Signaling Pathways
- Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ
Papers in
- Cell Biology 10
- Hippo pathway signaling and YAP/TAZ 6
- Cellular Mechanics and Interactions 3
-
- Protease and Inhibitor Mechanisms 7
- NF-κB Signaling Pathways 5
- Co-authors
- Andrew C. Newby (29 shared papers)Andrew Howard Baker (5 shared papers)Graciela B. Sala‐Newby (21 shared papers)Rosalind P. Fabunmi (1 shared paper)Gillian Murphy (3 shared papers)Andrew C. Newby (5 shared papers)Quteba Ebrahem (1 shared paper)Nina Zobenica Moore (1 shared paper)
- Journals
- Journal of Molecular and Cellular Cardiology (5 papers)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (4 papers)Journal of Biological Chemistry (4 papers)Scientific Reports (3 papers)Cardiovascular Research (3 papers)
- Partner nations
- United KingdomTaiwanUnited States
In The Last Decade
Mark Bond
43 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 87
- Cancer Research 890
- Cell Biology 286
- Biochemistry 92
- Molecular Biology 819
- Immunology 217
Countries citing papers authored by Mark Bond
This map shows the geographic impact of Mark Bond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bond more than expected).
Fields of papers citing papers by Mark Bond
This network shows the impact of papers produced by Mark Bond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bond. The network helps show where Mark Bond may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Bond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 570 | |
| 2 | 1998 | 470 | |
| 3 | 2001 | 333 | |
| 4 | 1999 | 160 | |
| 5 | 2002 | 156 | |
| 6 | 2002 | 125 | |
| 7 | 2000 | 106 | |
| 8 | 2008 | 98 | |
| 9 | 2010 | 89 | |
| 10 | 2019 | 79 | |
| 11 | 2018 | 78 | |
| 12 | 2015 | 75 | |
| 13 | 2006 | 67 | |
| 14 | 2002 | 56 | |
| 15 | 2004 | 54 | |
| 16 | 2008 | 54 | |
| 17 | 2019 | 48 | |
| 18 | 2008 | 41 | |
| 19 | 2017 | 35 | |
| 20 | 2009 | 34 |
About Mark Bond
Mark Bond is a scholar working on Cell Biology, Cancer Research, Molecular Biology, Immunology and Physiology, having authored 43 papers that have together received 3.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Protein Kinase Regulation and GTPase Signaling (8 papers), Protease and Inhibitor Mechanisms (7 papers), Hippo pathway signaling and YAP/TAZ (6 papers), NF-κB Signaling Pathways (5 papers), Nitric Oxide and Endothelin Effects (4 papers), Cellular Mechanics and Interactions (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). The work is most often cited by research in Cancer Research (890 citations), Cell Biology (286 citations), Biochemistry (92 citations), Molecular Biology (819 citations) and Immunology (217 citations). Mark Bond has collaborated with scholars based in United Kingdom, Taiwan and United States. Frequent co-authors include Andrew C. Newby, Andrew Howard Baker, Graciela B. Sala‐Newby, Rosalind P. Fabunmi, Gillian Murphy, Andrew C. Newby, Quteba Ebrahem, Nina Zobenica Moore, Bela Anand‐Apte and Lena Claesson. Their work appears in journals such as Journal of Molecular and Cellular Cardiology, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Journal of Biological Chemistry, Scientific Reports and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.